Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreIQVIA’s Regional Prescription Analysis provides sub-national level reporting of dispensed data for tailored markets, at product or pack level, linked to practice or pharmacy bricks.
Contact us for more information
IQVIA's Regional Prescription Analysis (RxA) sits within the IQVIA Prescription Based Services (PBS) suite and is a key component of the leading community pharmacy prescription platform, providing a complete and holistic view of market demand.
Covering the primary care market using data collected through patient medical record (PMR) systems, the national level audit (Xponent BPI) gives visibility on what has been prescribed and dispensed for individual prescriptions, while the sub-national level audit (RxA) provides information on what has been dispensed at a brick level.
Subscribe free of charge to IQVIA's Market Intelligence Newsletter to receive exclusive content on the latest key market insights and trends from the UK healthcare industry.
Providing a complete and holistic view of primary retail market demand at sub-national level
A longitudinal pharmacy dispensation dataset, used for tracking patient prescription activity with the ability to drill down to sub-national data
